Sfoglia per Autore
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast
2005-01-01 Mastropasqua, Mg; Maiorano, Eugenio; Pruneri, G; Orvieto, E; Mazzarol, G; Vento, Ar; Viale, G.
Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel node biopsy. A study of 1228 patients treated in a single institution including 116 patients with isolated tumor cells only in the sentinel lymph nodes
2005-01-01 Viale, G; Maiorano, Eugenio; Pruneri, G; Mastropasqua, Mg; Galimberti, V; Zurrida, S; Maisonneuve, P; Paganelli, G; Mazzarol, G.
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy
2005-01-01 Viale, G.; Maiorano, E.; Pruneri, G.; Mastropasqua, M. G.; Valentini, S.; Galimberti, V.; Zurrida, S.; Maisonneuve, P.; Paganelli, G.; Mazzarol, G.
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays
2006-01-01 Regan, Mm; Viale, G; Mastropasqua, Mg; Maiorano, Eugenio; Golouh, R; Carbone, A; Brown, B; Suurkula, M; Langman, G; Mazzucchelli, L; Braye, S; Grigolato, P; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Coates, As; Goldhirsch, A; Gusterson, B; INTERNATIONAL BREAST CANCER STUDY, Group
Diagnostic and therapeutic management of carcinoma of unknown primary: Histopathological and molecular diagnosis
2006-01-01 Viale, G.; Mastropasqua, M. G.
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report
2006-01-01 Rocco, B.; de Cobelli, O.; Leon, M. E.; Ferruti, M.; Mastropasqua, M. G.; Matei, D. V.; Gazzano, G.; Verweij, F.; Scardino, E.; Musi, G.; Djavan, B.; Rocco, F.
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience
2006-01-01 Viale, G.; Mastropasqua, M. G.; Maiorano, E.; Mazzarol, G.
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal women with early breast cancer: results from study BIG 1-98
2007-01-01 Viale, G; Regan, Mm; Maiorano, Eugenio; Mastropasqua, M; Dellorto, P; BRUUN RASMUSSEN, B; Raffoul, J; Neven, P; Orosz, Z; Braye, S; Ohlschlegel, C; Thuerlimann, B; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Goldhirsch, A; Gusterson, B; Coates, As
Chemo-endocrine versus endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors
2008-01-01 Viale, G; Regan, Mm; Maiorano, Eugenio; Mastropasqua, M; Golouh, R; Perin, T; Brown, Rw; Kovacs, A; Pillay, K; Ohlschlegel, C; Braye, S; Grigolato, P; Rusca, T; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Goldhirsch, A; Gusterson, B; Coates, As
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
2008-01-01 Viale, G; Regan, Mm; Mastropasqua, Mg; Maffini, F; Maiorano, Eugenio; Colleoni, M; Price, Kn; Golouh, R; Perin, T; Brown, Rw; Kovács, A; Pillay, K; Öhlschlegel, C; Gusterson, B; CASTIGLIONE GERTSCH, M; Gelber, Rd; Goldhirsch, A; Coates, As
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
2008-01-01 Ravaioli, A.; Monti, F.; Regan, M. M.; Maffini, F.; Mastropasqua, M. G.; Spataro, V.; Castiglione-Gertsch, M.; Panzini, I.; Gianni, L.; Goldhirsch, A.; Coates, A.; Price, K. N.; Gusterson, B. A.; Viale, G.
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
2008-01-01 Rasmussen, B. B.; Regan, M. M.; Lykkesfeldt, A. E.; Dell'Orto, P.; Del Curto, B.; Henriksen, K. L.; Mastropasqua, M. G.; Price, K. N.; Mery, E.; Lacroix-Triki, M.; Braye, S.; Altermatt, H. J.; Gelber, R. D.; Castiglione-Gertsch, M.; Goldhirsch, A.; Gusterson, B. A.; Thurlimann, B.; Coates, A. S.; Viale, G.
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis
2009-01-01 Rocco, B.; Matei, D. -V.; Melegari, S.; Ospina, J. C.; Mazzoleni, F.; Errico, G.; Mastropasqua, M.; Santoro, L.; Detti, S.; De Cobelli, O.
Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer
2009-01-01 Viale, G; Regan, Mm; Dell'Orto, P; Mastropasqua, Mg; Rasmussen, Bb; Macgrogan, G; Braye, S; Orosz, Z; Giobbie-Hurder, A; Neven, P; Knox, F; Oehlschlegel, C; Thuerlimann, B; Coates, As; Goldhirsch, A
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
2010-01-01 Viale, G; GIOBBIE HARDER A., GUSTERSON B; Maiorano, Eugenio; Mastropasqua, Mg; Sonzogni, A; Mallon, E; Colleoni, M; CASTIGLIONE GERTSCH, M; Regan, Mm; Price, Kn; Brown, Rw; Golouh, R; Crivellari, D; Karlsson, P; Öhlschlegel, C; Gelber, Rd; Goldhirsch, A; Coates, As
Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy is more effective in selected breast cancer subtypes: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
2010-01-01 Colleoni, M; Nolè, Bf; Viale, G; Regan, Mm; Price, Kn; Maiorano, Eugenio; Mastropasqua, Mg; Crivellari, D; Gelber, Rd; Goldhirsch, A; Coates, As; Gusterson, B.
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
2010-01-01 Maiorano, Eugenio; Regan, Mm; Viale, G; Mastropasqua, Mg; Colleoni, M; CASTIGLIONE GERTSCH, M; Price, Kn; Gelber, Rd; Goldhirsch, A; Coates, As
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies
2010-01-01 Viale, G.; Ghioni, M.; Mastropasqua, M. G.
What can the pathologist offer for optimal treatment choice?
2010-01-01 Viale, G; Mastropasqua, M G
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features
2010-01-01 Montagna, E.; Bagnardi, V.; Rotmensz, N.; Viale, G.; Pruneri, G.; Veronesi, P.; Cancello, G.; Balduzzi, A.; Dellapasqua, S.; Cardillo, A.; Luini, A.; Zurrida, S.; Gentilini, O.; Mastropasqua, M. G.; Bottiglieri, L.; Iorfida, M.; Goldhirsch, A.; Colleoni, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast | 1-gen-2005 | Mastropasqua, Mg; Maiorano, Eugenio; Pruneri, G; Orvieto, E; Mazzarol, G; Vento, Ar; Viale, G. | |
| Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel node biopsy. A study of 1228 patients treated in a single institution including 116 patients with isolated tumor cells only in the sentinel lymph nodes | 1-gen-2005 | Viale, G; Maiorano, Eugenio; Pruneri, G; Mastropasqua, Mg; Galimberti, V; Zurrida, S; Maisonneuve, P; Paganelli, G; Mazzarol, G. | |
| Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy | 1-gen-2005 | Viale, G.; Maiorano, E.; Pruneri, G.; Mastropasqua, M. G.; Valentini, S.; Galimberti, V.; Zurrida, S.; Maisonneuve, P.; Paganelli, G.; Mazzarol, G. | |
| Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays | 1-gen-2006 | Regan, Mm; Viale, G; Mastropasqua, Mg; Maiorano, Eugenio; Golouh, R; Carbone, A; Brown, B; Suurkula, M; Langman, G; Mazzucchelli, L; Braye, S; Grigolato, P; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Coates, As; Goldhirsch, A; Gusterson, B; INTERNATIONAL BREAST CANCER STUDY, Group | |
| Diagnostic and therapeutic management of carcinoma of unknown primary: Histopathological and molecular diagnosis | 1-gen-2006 | Viale, G.; Mastropasqua, M. G. | |
| Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report | 1-gen-2006 | Rocco, B.; de Cobelli, O.; Leon, M. E.; Ferruti, M.; Mastropasqua, M. G.; Matei, D. V.; Gazzano, G.; Verweij, F.; Scardino, E.; Musi, G.; Djavan, B.; Rocco, F. | |
| Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience | 1-gen-2006 | Viale, G.; Mastropasqua, M. G.; Maiorano, E.; Mazzarol, G. | |
| Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal women with early breast cancer: results from study BIG 1-98 | 1-gen-2007 | Viale, G; Regan, Mm; Maiorano, Eugenio; Mastropasqua, M; Dellorto, P; BRUUN RASMUSSEN, B; Raffoul, J; Neven, P; Orosz, Z; Braye, S; Ohlschlegel, C; Thuerlimann, B; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Goldhirsch, A; Gusterson, B; Coates, As | |
| Chemo-endocrine versus endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors | 1-gen-2008 | Viale, G; Regan, Mm; Maiorano, Eugenio; Mastropasqua, M; Golouh, R; Perin, T; Brown, Rw; Kovacs, A; Pillay, K; Ohlschlegel, C; Braye, S; Grigolato, P; Rusca, T; Gelber, Rd; CASTIGLIONE GERTSCH, M; Price, Kn; Goldhirsch, A; Gusterson, B; Coates, As | |
| Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer | 1-gen-2008 | Viale, G; Regan, Mm; Mastropasqua, Mg; Maffini, F; Maiorano, Eugenio; Colleoni, M; Price, Kn; Golouh, R; Perin, T; Brown, Rw; Kovács, A; Pillay, K; Öhlschlegel, C; Gusterson, B; CASTIGLIONE GERTSCH, M; Gelber, Rd; Goldhirsch, A; Coates, As | |
| p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer | 1-gen-2008 | Ravaioli, A.; Monti, F.; Regan, M. M.; Maffini, F.; Mastropasqua, M. G.; Spataro, V.; Castiglione-Gertsch, M.; Panzini, I.; Gianni, L.; Goldhirsch, A.; Coates, A.; Price, K. N.; Gusterson, B. A.; Viale, G. | |
| Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial | 1-gen-2008 | Rasmussen, B. B.; Regan, M. M.; Lykkesfeldt, A. E.; Dell'Orto, P.; Del Curto, B.; Henriksen, K. L.; Mastropasqua, M. G.; Price, K. N.; Mery, E.; Lacroix-Triki, M.; Braye, S.; Altermatt, H. J.; Gelber, R. D.; Castiglione-Gertsch, M.; Goldhirsch, A.; Gusterson, B. A.; Thurlimann, B.; Coates, A. S.; Viale, G. | |
| Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis | 1-gen-2009 | Rocco, B.; Matei, D. -V.; Melegari, S.; Ospina, J. C.; Mazzoleni, F.; Errico, G.; Mastropasqua, M.; Santoro, L.; Detti, S.; De Cobelli, O. | |
| Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer | 1-gen-2009 | Viale, G; Regan, Mm; Dell'Orto, P; Mastropasqua, Mg; Rasmussen, Bb; Macgrogan, G; Braye, S; Orosz, Z; Giobbie-Hurder, A; Neven, P; Knox, F; Oehlschlegel, C; Thuerlimann, B; Coates, As; Goldhirsch, A | |
| Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer | 1-gen-2010 | Viale, G; GIOBBIE HARDER A., GUSTERSON B; Maiorano, Eugenio; Mastropasqua, Mg; Sonzogni, A; Mallon, E; Colleoni, M; CASTIGLIONE GERTSCH, M; Regan, Mm; Price, Kn; Brown, Rw; Golouh, R; Crivellari, D; Karlsson, P; Öhlschlegel, C; Gelber, Rd; Goldhirsch, A; Coates, As | |
| Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy is more effective in selected breast cancer subtypes: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer | 1-gen-2010 | Colleoni, M; Nolè, Bf; Viale, G; Regan, Mm; Price, Kn; Maiorano, Eugenio; Mastropasqua, Mg; Crivellari, D; Gelber, Rd; Goldhirsch, A; Coates, As; Gusterson, B. | |
| Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy | 1-gen-2010 | Maiorano, Eugenio; Regan, Mm; Viale, G; Mastropasqua, Mg; Colleoni, M; CASTIGLIONE GERTSCH, M; Price, Kn; Gelber, Rd; Goldhirsch, A; Coates, As | |
| Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies | 1-gen-2010 | Viale, G.; Ghioni, M.; Mastropasqua, M. G. | |
| What can the pathologist offer for optimal treatment choice? | 1-gen-2010 | Viale, G; Mastropasqua, M G | |
| Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features | 1-gen-2010 | Montagna, E.; Bagnardi, V.; Rotmensz, N.; Viale, G.; Pruneri, G.; Veronesi, P.; Cancello, G.; Balduzzi, A.; Dellapasqua, S.; Cardillo, A.; Luini, A.; Zurrida, S.; Gentilini, O.; Mastropasqua, M. G.; Bottiglieri, L.; Iorfida, M.; Goldhirsch, A.; Colleoni, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile